Medtronic Plc MDT

Revenue Intelligence Report • 36 quarters of SEC filing data • Updated 2026-03-15

Medtronic Plc has a forecasted full-year revenue of $36B, a +3.5% year-over-year change, based on 36 quarters of SEC filing data. Key revenue drivers include SG&A (elasticity 1.04x). The ARDL model achieves strong accuracy at 2.0% MAPE.

Investment Thesis

Our ARDL model tracks Medtronic Plc's revenue with exceptional precision (2.0% MAPE), indicating highly predictable cash flows. Sales & marketing spend shows a 1.04x elasticity, suggesting effective go-to-market execution.

Next FY Revenue
$36.1B
+3.5% YoY
SG&A Elasticity
1.04x
Model Accuracy
2.0% MAPE
Holdout validation: The model predicted $8.7B vs the actual $9.0B — an error of 3.3%.
Note: Medtronic Plc does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

MDT Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q1 2026 $8.7B $9.0B $8.3B – $9.2B +3.8% ✓ In range
Q2 2026 $8.8B $8.2B – $9.5B +6.4%
Q3 2026 $8.9B $8.2B – $9.8B +4.3%
Q4 2026 $9.1B $8.2B – $10B +1.3%
Q1 2027 $9.2B $8.2B – $10B +2.1%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Medtronic Plc's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 1.0029 +0.3% In line with trend 12
FQ2 (Dec–Feb) 1.0179 +1.8% In line with trend 12
FQ3 (Mar–May) 1.0 +0.0% In line with trend 0
FQ4 (Jun–Aug) 0.9952 -0.5% In line with trend 11

How Spending Drives Revenue

MDT Spending Timing
Reading this chart: Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

COO A REGN CI BIIB DGX PODD RMD